Equity
€2,000 from €230,516 in 2024
Equity fell by 99% in 1 year.
BE PSY MED
Lifetime
4 annual accounts with figures on one time axispeak €140,092 (2025)
€140,092▲ 21.2%
peak €92,706 (2025)
€92,706▲ 11.8%
peak €230,516 (2024)
€2,000▼ 99.1%
€356,659▲ 711%
Board1 name since 2021
1 director
Documentsfilings and deeds
24-06-202637 days before the deadline
2025micro format
Gross margin from €115,588 to €140,092Dividend €321,223Equity from €230,516 to €2,000Debts from €43,963 to €356,659Cash from €222,914 to €327,880
Key points
from the 2025 annual accountsTurnover
≈ €260,000 estimated
The micro format states no turnover.
Debts
€356,659 99% of the balance sheet
Financial debts 4%Suppliers 0%Taxes and wages 15%Other 80%
Of this, €342,983 falls due within a year.
Liquidity
0.96 was 13.80 in 2024
Short-term debts rose from €17,035 to €342,983.
Filings
4 annual accounts since 2022
The last four annual accounts were filed 26 to 41 days before the end of the period.
Position in the sector
0.6%
Lower solvency than 95% of companies in human health. Sector median 63.0% · 21,334 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,156 companies had the same profile as BE PSY MED has now. Each dot stands for 6 companies, two years later.
94.1%
were still trading
2.8%
stopped another way
3.0%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,156 companies, not a prediction for BE PSY MED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0777773219
Registered office moved from Cuesmes to Colfontaine
New registered office: Rue du Tour 32F, 7340 Colfontaine · Previous registered office: 12, bte 3, Rue du Curoir, 7033 Cuesmes · General meeting of 22-04-2022 · Gazette deed
Incorporation
Founding capital of €2,000, 100 shares · Founder: (comparante) · Appointment: (director) · published on 30-11-2021 · Gazette deed
First establishment
Rue du Curoir (C.) 3, Mons
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| BE PSY MED Colfontaine | €358,659 | €140,092 | 0.6% | - |
| Dr Emmanuelle Papleux Enghien | €380,037 | €147,690 | 65.5% | - |
| CABINET DERMATOLOGIE BONARDEAUX Geer | €355,096 | €142,847 | 12.7% | - |
| AMBAX Merelbeke-Melle | €365,244 | €148,826 | 63.7% | - |
| Cabinet Médical du Docteur WILLEME SRL Liège | €384,560 | €146,204 | 76.8% | - |
| Levexia Antwerp | €357,960 | €156,267 | 9.7% | - |
| Dr Laurie SWENEN Dison | €327,502 | €152,740 | 34.7% | - |
These companies have the same main activity as BE PSY MED: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €328,000 and €385,000, founded between 2021 and 2022.
Official details
Source: KBO- Status
- Active since 26-11-2021Normal situation
- Activity
- Specialist medical practiceNACE 86220and 1 other
- Establishment unit
- 2.327.271.8077033 Mons, since 26-11-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 18-02-2026
Annual accounts 2025
- €358,659▲ 30.7%
- Filing
- Filed on 24-06-2026, 37 days before the end of the filing period
Insights on BE PSY MED
BE PSY MED files the micro format. That format states no turnover. The gross margin rose from €95,945 in 2022 to €140,092 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BE PSY MED
- What is the company number of BE PSY MED?
- The company number of BE PSY MED is 0777.773.219. The VAT number is the same number with BE in front: BE 0777.773.219.
- Where is BE PSY MED based?
- The registered office is at Rue du Tour 32 F, 7340 Colfontaine.Company details
- What does BE PSY MED do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of BE PSY MED?
- BE PSY MED is a private limited company (BV).
- When was BE PSY MED founded?
- BE PSY MED was founded on 26-11-2021.
- Is BE PSY MED still active?
- Yes, BE PSY MED is an active enterprise in the KBO register.
- What is the turnover of BE PSY MED?
- The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €140,092 and 40 comparable companies (NACE 86220). It probably lies between €220,000 and €350,000.Financials
- Is BE PSY MED profitable?
- In financial year 2025, BE PSY MED made a profit of €92,706.
- Where can I find the annual accounts of BE PSY MED?
- BE PSY MED filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BE PSY MED due?
- BE PSY MED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.